ViiV Healthcare Announces Data Demonstrating Dovato (DTG/3TC) Is Highly Effective in Treatment-Naïve People With Advanced HIV ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will ...
This is dangerous on multiple levels and AI Washing, as it is called, is already endemic across the business landscape. For ...
Located in Southeast Atlanta, the 825,000 square feet state-of-the-art bulk industrial development was completed on time and ...
GSK cut its full-year vaccine sales outlook after key shots for respiratory syncytial virus and shingles missed expectations ...
GSK has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. The UK ...
The effort by the Center for Regenerative Medicine of Boston University, Boston Medical Center, and GSK aims to find new ...
Don’t invest unless prepared to lose all the money you invest. This is a high-risk investment, you shouldn’t expect to be protected if something goes wrong. GlaxoSmithKline (GSK)—a global ...
A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...
North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global healthcare company has made a huge difference in the biotech scene here, ...
The company aims to continue this momentum amid a growing demand for diabetes care products. Legal troubles loom large as GlaxoSmithKline files a lawsuit against Moderna for alleged patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback